Guideline Development Group

References

1. Beckman MG, Hooper WC, Critchley SE, Ortel TL. Venous thromboembolism: a public health concern. Am. J. Prev. Med. 2010;38(4):S495-501.

2. Kahn SR, Ducruet T, Lamping DL, et al. Prospective evaluation of health-related quality of life in patients with deep venous thrombosis. Arch. Intern. Med. 2005;165(10):1173-1178.

3. Committee on Standards for Developing Trustworthy Clinical Practice Guidelines. Clinical Practice Guidelines We Can Trust. Washington DC: The National Academies Press; 2011.

4. White RH. The Epidemiology of Venous Thromboembolism. Circulation. 2003;107(23 suppl 1):I-4-I-8.

5. Klok FA, van der Hulle T, den Exter PL, Lankeit M, Huisman MV, Konstantinides S. The post-PE syndrome: a new concept for chronic complications of pulmonary embolism. Blood Rev. 2014.

6. World Health Organization. WHO research into global hazards of travel (WRIGHT) project. http://www.who.int/cardiovascular_diseases/wright_project/phase1_report/WRIGHT%20REPORT.pdf?us=1. Published: 2007.

7. Cohen AT, Agnelli G, Anderson FA, et al. Venous thromboembolism (VTE) in Europe. The number of VTE events and associated morbidity and mortality. Thromb. Haemost. 2007;98(4):756-764.

8. Galson SK. The Surgeon General’s Call to Action to Prevent Deep Vein Thrombosis and Pulmonary Embolism. U.S. Department of Health and Human Services; 2008.

9. Korkmaz A, Ozlu T, Ozsu S, Kazaz Z, Bulbul Y. Long-term outcomes in acute pulmonary thromboembolism: the incidence of chronic thromboembolic pulmonary hypertension and associated risk factors. Clin Appl Thromb Hemost. 2012;18(3):281-288.

10. Klok FA, van Kralingen KW, van Dijk AP, et al. Quality of life in long-term survivors of acute pulmonary embolism. Chest. 2010;138(6):1432-1440.

11. Kahn SR, Shapiro S, Wells PS, et al. Compression stockings to prevent post-thrombotic syndrome: a randomised placebo-controlled trial. Lancet. 2014;383(9920):880-888.

12. Streiff MB, Brady JP, Grant AM, Grosse SD, Wong B, Popovic T. CDC Grand Rounds: preventing hospital-associated venous thromboembolism. MMWR. Morb. Mortal. Wkly. Rep. 2014;63(9):190-193.

13. Kaplan SL, Coulter C, Fetters L. Developing evidence-based physical therapy clinical practice guidelines. Pediatr Phys Ther. 2013;25(3):257-270.

14. Fetters L, Tilson J. Evidence Based Physical Therapy. Philadelphia, PA: F.A. Davis Company; 2012.

15. Shea B, Grimshaw J, Wells G, et al. Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews. BMC Medical Research Methodology. 2007;7(1):10.

16. Canadian Institutes of Health Research. Advancing the science of practice guidelines. http://www.agreetrust.org/. Accessed December 2, 2014.

17. Shiffman RN, Michel G, Rosenfeld RM, Davidson C. Building better guidelines with BRIDGE-Wiz: development and evaluation of a software assistant to promote clarity, transparency, and implementability. J. Am. Med. Inform. Assoc. 2012;19(1):94-101.

18. Rocha AT, Paiva EF, Lichtenstein A, Milani R, Jr., Cavalheiro CF, Maffei FH. Risk-assessment algorithm and recommendations for venous thromboembolism prophylaxis in medical patients. Vasc Health Risk Manag. 2007;3(4):533-553.

19. National Institute for Health and Care Excellence. Venous thromboembolism: reducing the risk: Reducing the risk of venous thromboembolism (deep vein thrombosis and pulmonary embolism) in patients admitted to hospital. National Institute for Health and Care Excellence; 2010.

20. Wells PS, Anderson DR, Bormanis J, et al. Value of assessment of pretest probability of deep-vein thrombosis in clinical management. Lancet. 1997;350(9094):1795-1798.

21. Alikhan R, Cohen AT. A safety analysis of thromboprophylaxis in acute medical illness. Thromb. Haemost. 2003;89(3):590-591.

22. Samama MM. An epidemiologic study of risk factors for deep vein thrombosis in medical outpatients: the Sirius study. Arch. Intern. Med. 2000;160(22):3415-3420.

23. Motykie GD, Caprini JA, Arcelus JI, et al. Risk factor assessment in the management of patients with suspected deep venous thrombosis. Int. Angiol. 2000;19(1):47-51.

24. Weill-Engerer S, Meaume S, Lahlou A, et al. Risk factors for deep vein thrombosis in inpatients aged 65 and older: a case-control multicenter study. J. Am. Geriatr. Soc. 2004;52(8):1299-1304.

25. Bates SM, Jaeschke R, Stevens SM, et al. Diagnosis of DVT: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141(2 Suppl):e351S-418S.

26. Guyatt GH, Akl EA, Crowther M, Gutterman DD, Schuunemann HJ. Executive summary: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141(2 Suppl):7S-47S.

27. Aissaoui N, Martins E, Mouly S, Weber S, Meune C. A meta-analysis of bed rest versus early ambulation in the management of pulmonary embolism, deep vein thrombosis, or both. Int. J. Cardiol. 2009;137(1):37-41.

28. Kahn SR, Shrier I, Kearon C. Physical activity in patients with deep venous thrombosis: a systematic review. Thromb. Res. 2008;122(6):763-773.

29. American Physical Therapy Association. Guide to Physical Therapist Practice. 2003; Revised 2nd Edition:http://guidetoptpractice.apta.org/. Accessed May 28, 2014.

30. Finnish Medical Society Duodecim. Deep vein thrombosis. Helsinki, Finland: Wiley Interscience; 2011.

31. Qaseem A, Chou R, Humphrey LL, Starkey M, Shekelle P. Venous thromboembolism prophylaxis in hospitalized patients: a clinical practice guideline from the American College of Physicians. Ann. Intern. Med. 2011;155(9):625-632.

32. Woller SC, Stevens SM, Jones JP, et al. Derivation and validation of a simple model to identify venous thromboembolism risk in medical patients. Am. J. Med. 2011;124(10):947-954 e942.

33. Kucher N, Tapson VF, Goldhaber SZ. Risk factors associated with symptomatic pulmonary embolism in a large cohort of deep vein thrombosis patients. Thromb. Haemost. 2005;93(3):494-498.

34. Prevention of Venous Thromboembolism: Brief Update Review. In: Agency for Healthcare Research and Quality (US), ed. Making Health Care Safer II: An Updated Critical Analysis of the Evidence for Patient Safety Practices.2013.

35. Scottish Intercollegiate Guidelines Network (SIGN). Prevention and management of venous thromboembolism: a national clinical guideline. Edinburgh, Scotland: Scottish Intercollegiate Guidelines Network (SIGN); 2011.

36. Cohen AT, Tapson VF, Bergmann JF, et al. Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): a multinational cross-sectional study. Lancet. 2008;371(9610):387-394.

37. Kahn SR, Lim W, Dunn AS, et al. Prevention of VTE in nonsurgical patients: Antithrombotic therapy and prevention of thrombosis, 9th ed: american college of chest physicians evidence-based clinical practice guidelines. Chest. 2012;141(2_suppl):e195S-e226S.

38. Barbar S, Noventa F, Rossetto V, et al. A risk assessment model for the identification of hospitalized medical patients at risk for venous thromboembolism: the Padua Prediction Score. J Thromb Haemost. 2010;8(11):2450-2457.

39. Rosenberg D, Eichorn A, Alarcon M, McCullagh L, McGinn T, Spyropoulos AC. External Validation of the Risk Assessment Model of the International Medical Prevention Registry on Venous Thromboembolism (IMPROVE) for Medical Patients in a Tertiary Health System. Journal of the American Heart Association. 2014;3(6).

40. Autar R. The management of deep vein thrombosis: the Autar DVT risk assessment scale re-visited. Journal of orthopaedic nursing. 2003;7:114-124.

41. Nendaz M, Spirk D, Kucher N, et al. Multicentre validation of the Geneva Risk Score for hospitalised medical patients at risk of venous thromboembolism. Explicit ASsessment of Thromboembolic RIsk and Prophylaxis for Medical PATients in SwitzErland (ESTIMATE). Thromb. Haemost. 2014;111(3):531-538.

42. Dupras D. BJ, Felty C., Hansen C., Johnson T., Lim K., Maddali S., Marshall P., Messner P., Skeik , N. Institute for Clinical Systems Improvement. Venous Thromboembolism Diagnosis and Treatment. http://bit.ly/VTE0113. Published: Updated January 2013, .

43. Zarowitz BJ, Tangalos E, Lefkovitz A, et al. Thrombotic risk and immobility in residents of long-term care facilities. J Am Med Dir Assoc. 2010;11(3):211-221.

44. Sachdeva A, Dalton M, Amaragiri SV, Lees T. Elastic compression stockings for prevention of deep vein thrombosis. Cochrane Database Syst Rev. 2010(7):CD001484.

45. Clarke M, Hopewell S, Juszczak E, Eisinga A, Kjeldstrom M. Compression stockings for preventing deep vein thrombosis in airline passengers. Cochrane Database Syst Rev. 2006(2):CD004002.

46. Kahn SR, Springmann V, Schulman S, et al. Management and adherence to VTE treatment guidelines in a national prospective cohort study in the Canadian outpatient setting. The Recovery Study. Thromb. Haemost. 2012;108(3):493-498.

47. Philbrick JT, Shumate R, Siadaty MS, Becker DM. Air travel and venous thromboembolism: a systematic review. J. Gen. Intern. Med. 2007;22(1):107-114.

48. Amaragiri SV, Lees TA. Elastic compression stockings for prevention of deep vein thrombosis. Cochrane Database Syst Rev. 2000(3):CD001484.

49. Agu O, Hamilton G, Baker D. Graduated compression stockings in the prevention of venous thromboembolism. Br. J. Surg. 1999;86(8):992-1004.

50. Sajid MS, Desai M, Morris RW, Hamilton G. Knee length versus thigh length graduated compression stockings for prevention of deep vein thrombosis in postoperative surgical patients. Cochrane Database Syst Rev. 2012;5:CD007162.

51. Guidelines for the diagnosis, treatment and prevention of pulmonary thromboembolism and deep vein thrombosis (JCS 2009). Circ J. 2011;75(5):1258-1281.

52. Spencer FA, Lessard D, Emery C, Reed G, Goldberg RJ. Venous thromboembolism in the outpatient setting. Arch. Intern. Med. 2007;167(14):1471-1475.

53. Kakkos SK, Caprini JA, Geroulakos G, Nicolaides AN, Stansby GP, Reddy DJ. Combined intermittent pneumatic leg compression and pharmacological prophylaxis for prevention of venous thromboembolism in high-risk patients. Cochrane Database Syst Rev. 2008(4):CD005258.

54. Dennis M, Sandercock P, Reid J, et al. Can clinical features distinguish between immobile patients with stroke at high and low risk of deep vein thrombosis? Statistical modelling based on the CLOTS trials cohorts. J. Neurol. Neurosurg. Psychiatry. 2011;82(10):1067-1073.

55. Bono CM, Watters WC, 3rd, Heggeness MH, et al. An evidence-based clinical guideline for the use of antithrombotic therapies in spine surgery. Spine J. 2009;9(12):1046-1051.

56. Falck-Ytter Y, Francis CW, Johanson NA, et al. Prevention of VTE in orthopedic surgery patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141(2 Suppl):e278S-325S.

57. Mont MA, Jacobs JJ. AAOS clinical practice guideline: preventing venous thromboembolic disease in patients undergoing elective hip and knee arthroplasty. J. Am. Acad. Orthop. Surg. 2011;19(12):777-778.

58. Windisch C, Kolb W, Kolb K, Grutzner P, Venbrocks R, Anders J. Pneumatic compression with foot pumps facilitates early postoperative mobilisation in total knee arthroplasty. Int. Orthop. 2011;35(7):995-1000.

59. University of Michigan Health System. Venous Thromboembolism (VTE). http://www.med.umich.edu/1info/FHP/practiceguides/vte/vte.pdf. Published: 2009.

60. Scottish Intercollegiate Guidelines Network. Antithrombotics: Indications and Management: a national clinical guideline. Edinburgh, Scotland: Scottish Intercollegiate Guidelines Network; 2013.

61. Goodacre S, Sutton AJ, Sampson FC. Meta-analysis: The value of clinical assessment in the diagnosis of deep venous thrombosis. Ann. Intern. Med. 2005;143(2):129-139.

62. Wells PS, Hirsh J, Anderson DR, et al. Accuracy of clinical assessment of deep-vein thrombosis. Lancet. 1995;345(8961):1326-1330.

63. Wells PS, Owen C, Doucette S, Fergusson D, Tran H. Does this patient have deep vein thrombosis? JAMA. 2006;295(2):199-207.

64. Geersing GJ, Zuithoff NP, Kearon C, et al. Exclusion of deep vein thrombosis using the Wells rule in clinically important subgroups: individual patient data meta-analysis. BMJ. 2014;348:g1340.

65. Wells PS, Anderson DR, Rodger M, et al. Evaluation of D-dimer in the diagnosis of suspected deep-vein thrombosis. N. Engl. J. Med. 2003;349(13):1227-1235.

66. Oudega R, Moons KG, Hoes AW. Ruling out deep venous thrombosis in primary care. A simple diagnostic algorithm including D-dimer testing. Thromb. Haemost. 2005;94(1):200-205.

67. van der Velde EF, Toll DB, ten Cate-Hoek AJ, et al. Comparing the Diagnostic Performance of 2 Clinical Decision Rules to Rule Out Deep Vein Thrombosis in Primary Care Patients. The Annals of Family Medicine. 2011;9(1):31-36.

68. Hanley M. DJ, Rybicki F.J., Dill K.E., Bandyk D.F., Francois C.J., Gerhard-Herman M.D., Kalva S.P., Mohler E.R. III, Moriarty J.M., Oliva I.B., Schenker M.P., Strax R., Weiss C., Expert Panel on Vascular Imaging. ACR Appropriateness Criteria® suspected lower-extremity deep vein thrombosis. 2013; http://www.guideline.gov/content.aspx?id=23831. Accessed 3/26/2014.

69. National Institute for Health and Care Excellence. Venous thromboembolic diseases: the management of venous thromboembolic diseases and the role of thrombophilia testing. http://publications.nice.org.uk/venous-thromboembolic-diseases-the-management-of-venous-thromboembolic-diseases-and-the-role-of-cg144. Published: 2012.

70. Bounameaux H, Perrier A, Righini M. Diagnosis of venous thromboembolism: an update. Vasc. Med. 2010;15(5):399-406.

71. Mousa AY, Broce M, Gill G, Kali M, Yacoub M, AbuRahma AF. Appropriate Use of d-Dimer Testing Can Minimize Over-Utilization of Venous Duplex Ultrasound in a Contemporary High-Volume Hospital. Ann. Vasc. Surg. 2015;29(2):311-317.

72. Prell J, Rachinger J, Smaczny R, et al. D-dimer plasma level: a reliable marker for venous thromboembolism after elective craniotomy. J. Neurosurg. 2013;119(5):1340-1346.

73. Tripodi A. D-dimer testing in laboratory practice. Clin. Chem. 2011;57(9):1256-1262.

74. Dunn AS, Brenner A, Halm EA. The magnitude of an iatrogenic disorder: a systematic review of the incidence of venous thromboembolism for general medical inpatients. Thromb. Haemost. 2006;95(5):758-762.

75. Baglin TP, White K, Charles A. Fatal pulmonary embolism in hospitalised medical patients. J. Clin. Pathol. 1997;50(7):609-610.

76. Samama MM, Cohen AT, Darmon JY, et al. A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients. Prophylaxis in Medical Patients with Enoxaparin Study Group. N. Engl. J. Med. 1999;341(11):793-800.

77. Leizorovicz A, Cohen AT, Turpie AG, Olsson CG, Vaitkus PT, Goldhaber SZ. Randomized, placebo-controlled trial of dalteparin for the prevention of venous thromboembolism in acutely ill medical patients. Circulation. 2004;110(7):874-879.

78. Cohen AT, Davidson BL, Gallus AS, et al. Efficacy and safety of fondaparinux for the prevention of venous thromboembolism in older acute medical patients: randomised placebo controlled trial. BMJ. 2006;332(7537):325-329.

79. Keeling D, Baglin T, Tait C, et al. Guidelines on oral anticoagulation with warfarin - fourth edition. Br. J. Haematol. 2011;154(3):311-324.

80. Greaves M. Limitations of the laboratory monitoring of heparin therapy. Scientific and Standardization Committee Communications: on behalf of the Control of Anticoagulation Subcommittee of the Scientific and Standardization Committee of the International Society of Thrombosis and Haemostasis. Thromb. Haemost. 2002;87(1):163-164.

81. Sanofi US. Lovenox prescribing information. http://products.sanofi.us/lovenox/lovenox.html#Boxed%20Warning. Accessed December 19, 2014.

82. Vandiver JW, Vondracek TG. Antifactor Xa levels versus activated partial thromboplastin time for monitoring unfractionated heparin. Pharmacotherapy. 2012;32(6):546-558.

83. Linkins LA, Dans AL, Moores LK, et al. Treatment and prevention of heparin-induced thrombocytopenia: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141(2 Suppl):e495S-530S.

84. Tuzson A. How high is too high? INR and acute care physical therapy. Acute Care Perspectives. 2009.

85. Ageno W, Gallus AS, Wittkowsky A, Crowther M, Hylek EM, Palareti G. Oral anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141(2 Suppl):e44S-88S.

86. Cannegieter SC, Rosendaal FR, Wintzen AR, van der Meer FJ, Vandenbroucke JP, Briet E. Optimal oral anticoagulant therapy in patients with mechanical heart valves. N. Engl. J. Med. 1995;333(1):11-17.

87. van der Meer FJ, Rosendaal FR, Vandenbroucke JP, Briet E. Bleeding complications in oral anticoagulant therapy. An analysis of risk factors. Arch. Intern. Med. 1993;153(13):1557-1562.

88. Mont MA, Jacobs JJ, Boggio LN, et al. Preventing venous thromboembolic disease in patients undergoing elective hip and knee arthroplasty. J. Am. Acad. Orthop. Surg. 2011;19(12):768-776.

89. Ward C, Conner G, Donnan G, Gallus A, McRae S. Practical management of patients on apixaban: a consensus guide. Thromb J. 2013;11(1):27.

90. Kearon C, Akl EA, Comerota AJ, et al. Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141(2 Suppl):e419S-494S.

91. Aldrich D, Hunt DP. When can the patient with deep venous thrombosis begin to ambulate? Phys. Ther. 2004;84(3):268-273.

92. Brandjes DP, Buller HR, Heijboer H, et al. Randomised trial of effect of compression stockings in patients with symptomatic proximal-vein thrombosis. Lancet. 1997;349(9054):759-762.

93. Prandoni P, Lensing AW, Prins MH, et al. Below-knee elastic compression stockings to prevent the post-thrombotic syndrome: a randomized, controlled trial. Ann. Intern. Med. 2004;141(4):249-256.

94. Kahn SR, Comerota AJ, Cushman M, et al. The Postthrombotic Syndrome: Evidence-Based Prevention, Diagnosis, and Treatment Strategies: A Scientific Statement From the American Heart Association. Circulation. 2014.

95. Partsch H, Blattler W. Compression and walking versus bed rest in the treatment of proximal deep venous thrombosis with low molecular weight heparin. J. Vasc. Surg. 2000;32(5):861-869.

96. Blattler W, Partsch H. Leg compression and ambulation is better than bed rest for the treatment of acute deep venous thrombosis. Int. Angiol. 2003;22(4):393-400.

97. Bouman A, Cate-Hoek AT. Timing and duration of compression therapy after deep vein thrombosis. Phlebology. 2014;29(1 suppl):78-82.

98. American College of Radiology (ACR) SoIRS. ACR-SIR practice guideline for the performance of inferior vena cava (IVC) filter placement for the prevention of pulmonary embolism. 2010:13.

99. Veltkamp R, Rizos T, Horstmann S. Intracerebral bleeding in patients on antithrombotic agents. Semin. Thromb. Hemost. 2013;39(8):963-971.

100. Pieracci FM, Eachempati SR, Shou J, Hydo LJ, Barie PS. Use of long-term anticoagulation is associated with traumatic intracranial hemorrhage and subsequent mortality in elderly patients hospitalized after falls: analysis of the New York State Administrative Database. J. Trauma. 2007;63(3):519-524.

101. Inui TS, Parina R, Chang DC, Coimbra R. Mortality after ground-level fall in the elderly patient taking oral anticoagulation for atrial fibrillation/flutter: a long-term analysis of risk versus benefit. J Trauma Acute Care Surg. 2014;76(3):642-649; discussion 649-650.

102. Garvin R, Howard E. Are major bleeding events from falls more likely in patients on warfarin? J. Fam. Pract. 2006;55(2):159-160; discussion 159.

103. Garwood CL, Corbett TL. Use of anticoagulation in elderly patients with atrial fibrillation who are at risk for falls. Ann. Pharmacother. 2008;42(4):523-532.

104. Adams PF. Summary health statistics for the U.S. population: National Health Interview Survey, 2012. Vital Health Stat. 2013;10(259).

105. Centers for Disease Control and Prevention. Falls Among Older Adults: An Overview Web site. http://www.cdc.gov/HomeandRecreationalSafety/Falls/adultfalls.html. Accessed August 29, 2014.

106. National Institute for Health and Care Excellence. Falls: assessment and prevention of falls in older persons. 2013; http://www.nice.org.uk/CG161. Accessed August 21, 2014, NICE Clinical Guideline 161.

107. American Geriatrics Society. AGS Clinical Practice Guidelines: Prevention of Falls in Older Persons. 2010; http://www.medcats.com/FALLS/frameset.htm. Accessed July 21, 2010.

108. Moyer VA. Prevention of falls in community-dwelling older adults: U.S. Preventive Services Task Force recommendation statement. Ann. Intern. Med. 2012;157(3):197-204.

109. Feinberg WM, Blackshear JL, Laupacis A, Kronmal R, Hart RG. Prevalence, age distribution, and gender of patients with atrial fibrillation. Analysis and implications. Arch. Intern. Med. 1995;155(5):469-473.

110. Lippi G, Favaloro EJ, Cervellin G. Prevention of venous thromboembolism: focus on mechanical prophylaxis. Semin. Thromb. Hemost. 2011;37(3):237-251.

111. Kolbach DN, Sandbrink MW, Neumann HA, Prins MH. Compression therapy for treating stage I and II (Widmer) post-thrombotic syndrome. Cochrane Database Syst Rev. 2003(4):CD004177.

112. Wheeler AP, Bernard GR. Treating patients with severe sepsis. N. Engl. J. Med. 1999;340(3):207-214.

113. Jeanneret C, Aschwanden M, Staub D. Compression to prevent the postthrombotic syndrome. Phlebology. 2014;29(1 suppl):71-77.

114. Watson LI, Armon MP. Thrombolysis for acute deep vein thrombosis. Cochrane Database Syst Rev. 2004(4):CD002783.

115. Kahn SR, Lamping DL, Ducruet T, et al. VEINES-QOL/Sym questionnaire was a reliable and valid disease-specific quality of life measure for deep venous thrombosis. J. Clin. Epidemiol. 2006;59(10):1049-1056.

116. Roberts LN, Patel RK, Donaldson N, Bonner L, Arya R. Post-thrombotic syndrome is an independent determinant of health-related quality of life following both first proximal and distal deep vein thrombosis. Haematologica. 2014;99(3):e41-43.

117. Kahn SR. Measurement properties of the Villalta scale to define and classify the severity of the post-thrombotic syndrome. J Thromb Haemost. 2009;7(5):884-888.

118. Musani MH, Matta F, Yaekoub AY, Liang J, Hull RD, Stein PD. Venous compression for prevention of postthrombotic syndrome: a meta-analysis. Am. J. Med. 2010;123(8):735-740.

119. Kolbach DN, Sandbrink MW, Hamulyak K, Neumann HA, Prins MH. Non-pharmaceutical measures for prevention of post-thrombotic syndrome. Cochrane Database Syst Rev. 2004(1):CD004174.

120. Aschwanden M, Jeanneret C, Koller MT, Thalhammer C, Bucher HC, Jaeger KA. Effect of prolonged treatment with compression stockings to prevent post-thrombotic sequelae: a randomized controlled trial. J. Vasc. Surg. 2008;47(5):1015-1021.

121. Giannoukas AD, Labropoulos N, Michaels JA. Compression with or without early ambulation in the prevention of post-thrombotic syndrome: a systematic review. Eur. J. Vasc. Endovasc. Surg. 2006;32(2):217-221.

122. van der Velden S, Neumann H. The post-thrombotic syndrome and compression therapy. Phlebology. 2014;29(1 suppl):83-89.

123. Kahn SR, Elman E, Rodger MA, Wells PS. Use of elastic compression stockings after deep venous thrombosis: a comparison of practices and perceptions of thrombosis physicians and patients. J Thromb Haemost. 2003;1(3):500-506.

124. Ten Cate-Hoek AJ, Ten Cate H, Tordoir J, Hamulyak K, Prins MH. Individually tailored duration of elastic compression therapy in relation to incidence of the postthrombotic syndrome. J. Vasc. Surg. 2010;52(1):132-138.

125. Verhovsek M, Douketis JD, Yi Q, et al. Systematic review: D-dimer to predict recurrent disease after stopping anticoagulant therapy for unprovoked venous thromboembolism. Ann. Intern. Med. 2008;149(7):481-490, W494.

126. Prandoni P, Lensing AW, Cogo A, et al. The long-term clinical course of acute deep venous thrombosis. Ann. Intern. Med. 1996;125(1):1-7.

127. Kyrle PA, Rosendaal FR, Eichinger S. Risk assessment for recurrent venous thrombosis. Lancet. 2010;376(9757):2032-2039.

128. Jimenez D, Aujesky D, Moores L, et al. Simplification of the pulmonary embolism severity index for prognostication in patients with acute symptomatic pulmonary embolism. Arch. Intern. Med. 2010;170(15):1383-1389.

129. Penaloza A, Verschuren F, Meyer G, et al. Comparison of the unstructured clinician gestalt, the wells score, and the revised Geneva score to estimate pretest probability for suspected pulmonary embolism. Ann. Emerg. Med. 2013;62(2):117-124 e112.

130. Zondag W, Kooiman J, Klok FA, Dekkers OM, Huisman MV. Outpatient versus inpatient treatment in patients with pulmonary embolism: a meta-analysis. Eur. Respir. J. 2013;42(1):134-144.

131. Laporte S, Mismetti P, Decousus H, et al. Clinical predictors for fatal pulmonary embolism in 15,520 patients with venous thromboembolism: findings from the Registro Informatizado de la Enfermedad TromboEmbolica venosa (RIETE) Registry. Circulation. 2008;117(13):1711-1716.

132. Jimenez D, Aujesky D, Yusen RD. Risk stratification of normotensive patients with acute symptomatic pulmonary embolism. Br. J. Haematol. 2010;151(5):415-424.

133. Engel HJ, Needham DM, Morris PE, Gropper MA. ICU early mobilization: from recommendation to implementation at three medical centers. Crit. Care Med. 2013;41(9):S69-80.

134. Tapp H, Phillips SE, Waxman D, Alexander M, Brown R, Hall M. Multidisciplinary team approach to improved chronic care management for diabetic patients in an urban safety net ambulatory care clinic. Journal of the American Board of Family Medicine. 2012;25(2):245-246.

135. Carr ECJ, Brockbank K, Barrett RF. Improving pain management through interprofessional education: evaluation of a pilot project. Learning in Health & Social Care. 2003;2(1):6-17.

136. Ageno W, Garcia D, Aguilar MI, et al. Prevention and treatment of bleeding complications in patients receiving vitamin K antagonists, part 2: Treatment. Am. J. Hematol. 2009;84(9):584-588.

137. Shamian B, Chamberlain RS. The role for prophylaxis inferior vena cava filters in patients undergoing bariatric surgery: replacing anecdote with evidence. Am. Surg. 2012;78(12):1349-1361.

138. Duffett LD, Gandara E, Cheung A, Bose G, Forster AJ, Wells PS. Outcomes of patients requiring insertion of an inferior vena cava filter: a retrospective observational study. Blood Coagul. Fibrinolysis. 2014;25(3):266-271.